W. Yao, “Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation: Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF”, Mediterr J Hematol Infect Dis, vol. 14, no. 1, p. e2022025, Feb. 2022.